Akèy › Kansè pwostat › North Carolina
Etid klinik pou Kansè pwostat nan North Carolina
47 etid pou Kansè pwostat ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Duke University, Durham
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
- FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AdventHealth Infusion Center Asheville, Asheville
- Southeastern Medical Oncology Center-Clinton, Clinton
- AdventHealth Infusion Center Haywood, Clyde
- ak 6 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Margaret R Pardee Memorial Hospital, Hendersonville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Atrium Health Levine Cancer Institute, Charlotte
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 28, 2026 · NCT06095089DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Duke University Medical Center, Durham
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06800313This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Duke Cancer Center Cary, Cary
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke Cancer Center, Durham
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07028853High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Durham VA Medical Center, Durham, NC, Durham
- Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Durham VA Medical Center, Durham, NC, Durham
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT04038502Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Duke University Medical Center, Durham
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 15, 2026 · NCT07493512Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Associated Urologists of North Carolina (AUNC), Raleigh
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 14, 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Duke University Medical Center, Durham
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 11, 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Durham VA Medical Center, Durham
- CarolinaEast Medical Center, New Bern
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Urology Specialists of the Carolinas - University Place, Charlotte
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07723248The Vanguard Study: Testing a New Way to Screen for Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
Ap rekriteVolontè an sante akeyi
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898COMPASS Study for Metastatic Castration-resistant Prostate Cancer
- Duke University, Durham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Gason · Mizajou Aug 27, 2026 · NCT07050433Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Levine Cancer Institute, Charlotte
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 24, 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Duke University Medical Center, Durham
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 21, 2026 · NCT04221542A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Duke University medical center, Durham
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Aug 20, 2026 · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- ECU Health Oncology Kinston, Kinston
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Duke University Medical Center - Duke Cancer Center, Durham
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 17, 2026 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Duke University, Durham
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Duke Cancer Institute, Durham
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 10, 2026 · NCT06067841A Study of DM002 in Patients With Advanced Solid Tumors
- Carolina BioOncology Institute, LLC, Huntersville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06751329Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
- Duke University, Durham
Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Gason · Mizajou Aug 6, 2026 · NCT07144228Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health University City/LCI-University, Charlotte
- Levine Cancer Institute-Ballantyne, Charlotte
- ak 9 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- Wake Forest University Health Sciences, Winston-Salem
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT05691465A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Duke Cancer Center, Durham
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 9, 2026 · NCT07103018Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Levine Cancer Institute, Charlotte
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 9, 2026 · NCT05413421Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Duke University, Durham
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Jun 25, 2026 · NCT06457919Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07463833Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- W.G. Bill Hefner Medical Center, Salisbury
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jun 15, 2026 · NCT05422911Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Duke University Medical Center, Durham
Ap rekriteFaz 4
Laj 18 a 100 · Gason · Mizajou Jun 4, 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of North Carolina at Chapel Hill, Chapel Hill
- Durham VA Medical Center, Durham
- Duke Cancer Network, Durham
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Gason · Mizajou May 22, 2026 · NCT03151629Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
- W.G. Bill Hefner VA Medical Center, Salisbury
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Apr 13, 2026 · NCT04337580Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Durham VA Medical Center, Durham, NC, Durham
Ap rekriteFaz 2/3
Laj 18 ak plis · Gason · Mizajou Apr 8, 2026 · NCT04787744Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.